Kunkel Lori Anne bought ELVN

October 30, 2026 · Form 4 insider transaction

Kunkel Lori Anne bought 7,300 shares of Enliven Therapeutics, Inc. at $18.30 per share, a transaction worth $133.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.